Advances in Mass Spectrometry for the Characterisation and Bioanalysis of Antibody-Drug Conjugates
Posted on July 24, 2025
Arnaud Delobel, PhD, R&D and Innovation Director, Quality Assistance sa
www.quality-assistance.com
Abstract ADCs are complex compounds resulting from the coupling of cytotoxic small molecules to a monoclonal antibody. Their characterisation as well as their bioanalysis (quantification in biological fluids) remains challenging. Mass spectrometry at different levels (intact, middle, peptide) can be...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy















